The FTC's Stance On Generic Biologics
This year marks the 25th anniversary of the Hatch-Waxman Act in the United States, which created a pathway for generic drugs by means of an abbreviated version of a New Drug...To view the full article, register now.
Already a subscriber? Click here to view full article